NNVC ▼ -0.8% - NanoViricides, Inc.
$NNVC - NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
20-OCT-2026 08:45 AM ET
Share this post
More filings for $NNVC
NNVC ▼ -3.8% - NanoViricides, Inc.Oct 13, 2026NNVC ▲ +1.4% - NanoViricides, Inc.Oct 6, 2026NNVC ▲ +4.0% - NanoViricides, Inc.Sep 29, 2026NNVC ▼ -2.1% - NanoViricides, Inc.Sep 28, 2026NNVC ▲ +5.2% - NanoViricides, Inc.Sep 23, 2026NNVC ▼ -0.9% - NanoViricides, Inc.Sep 8, 2026
View full $NNVC filing history →💬 Comments
Loading comments…
Leave a comment